Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Nephrotic Syndrome Clinical Trials
Nephrotic Syndrome clinical trials are recruiting across 70 cities. Here are the cities with the most active studies:
Nephrotic Syndrome Trial Phases
17 research organizations are sponsoring nephrotic syndrome trials.
About Nephrotic Syndrome
Nephrotic syndrome is a kidney disorder characterized by heavy proteinuria, low blood albumin, high cholesterol, and swelling. It can be caused by various underlying conditions. Treatment targets the underlying cause and may include immunosuppressive medications and supportive care.
Clinical trials are advancing new treatments for nephrotic syndrome. Currently, 22 studies are recruiting a combined 3,657 participants across the United States. Research is being conducted by 17 organizations including University of Michigan, Boehringer Ingelheim, Dimerix Bioscience Pty Ltd and 14 others.
2026 Nephrotic Syndrome Research Landscape
As of July 2026, the nephrotic syndrome clinical trial landscape includes 22 actively recruiting studies across 70 cities in the United States. These studies are collectively seeking 3,657 participants, with an average enrollment target of 166 per study.
The research spans multiple phases of development: 8 studies are in PHASE2, 6 studies are in NA, 5 studies are in PHASE3, 1 study is in PHASE1. The presence of Phase 3 trials indicates that some nephrotic syndrome treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 17 different organizations, including University of Michigan, Boehringer Ingelheim, Dimerix Bioscience Pty Ltd, Biogen, Vertex Pharmaceuticals Incorporated, and 12 others. The large number of sponsors reflects significant research interest and investment in nephrotic syndrome treatment advancement.
Geographically, nephrotic syndrome trials are most concentrated in Los Angeles, California (9 trials); Miami, Florida (6 trials); New York, New York (5 trials); Atlanta, Georgia (4 trials); Loma Linda, California (4 trials) and 7 other cities.
Featured Nephrotic Syndrome Studies
Highlighted recruiting studies for nephrotic syndrome, selected by enrollment size and research scope.
Nephrotic Syndrome Study Network
Minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), and Membranous nephropathy (MN), generate an enormous individual and societal financial burden, accounting for approximately 12% of prevalent end stage renal disease (ESRD) cases (2005) at an annual cost in the US of more than $3 billion. However, the clinical classification of these diseases is widely believed to be inadequa...
NEPTUNE Match Study
NEPTUNE Match is an additional opportunity offered to NEPTUNE study participants to prospectively recruit and communicate patient-specific clinical trial matching with kidney patients and their physician investigators.
Recurrence Post-transplant Observational Study in Focal Segmental Glomerulosclerosis and Minimal Change Disease
The morbidity of recurrence of focal segmental glomerulosclerosis (FSGS) and minimal change disease (MCD) after transplant is well-recognized and include contemporary reduction in quality of life, edema, early graft loss and mortality. Efforts to understand its mechanisms and improve its treatment have been limited by small sample sizes in single center studies and misclassification in registry st...
Frequently Asked Questions About Nephrotic Syndrome Clinical Trials
Are there nephrotic syndrome clinical trials near me?
Yes, there are 22 nephrotic syndrome clinical trials currently recruiting across 70+ cities in the United States, including Los Angeles, California; Miami, Florida; New York, New York. Browse the studies above to find one at a location convenient for you.
How do I join a nephrotic syndrome clinical trial?
To join a nephrotic syndrome clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are nephrotic syndrome clinical trials free?
Yes, participation in nephrotic syndrome clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of nephrotic syndrome treatments are being studied?
Current nephrotic syndrome clinical trials are testing a range of approaches across PHASE2 (8 studies), NA (6 studies), PHASE3 (5 studies), PHASE1 (1 study). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 17 research organizations.
Is it safe to participate in nephrotic syndrome clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 16, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 16, 2026 · Data from ClinicalTrials.gov